JP2015508097A5 - - Google Patents

Download PDF

Info

Publication number
JP2015508097A5
JP2015508097A5 JP2014558258A JP2014558258A JP2015508097A5 JP 2015508097 A5 JP2015508097 A5 JP 2015508097A5 JP 2014558258 A JP2014558258 A JP 2014558258A JP 2014558258 A JP2014558258 A JP 2014558258A JP 2015508097 A5 JP2015508097 A5 JP 2015508097A5
Authority
JP
Japan
Prior art keywords
methyl
ethyl
chroman
amino
naphthalen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014558258A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015508097A (ja
JP6114316B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/051445 external-priority patent/WO2013124828A1/en
Publication of JP2015508097A publication Critical patent/JP2015508097A/ja
Publication of JP2015508097A5 publication Critical patent/JP2015508097A5/ja
Application granted granted Critical
Publication of JP6114316B2 publication Critical patent/JP6114316B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014558258A 2012-02-24 2013-02-22 カルシウム感知受容体調節剤としての置換クロマン化合物 Active JP6114316B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN178/KOL/2012 2012-02-24
IN178KO2012 2012-02-24
IN1030/KOL/2012 2012-09-07
IN1030KO2012 2012-09-07
PCT/IB2013/051445 WO2013124828A1 (en) 2012-02-24 2013-02-22 Substituted chroman compounds as calcium sensing receptor modulators

Publications (3)

Publication Number Publication Date
JP2015508097A JP2015508097A (ja) 2015-03-16
JP2015508097A5 true JP2015508097A5 (enExample) 2016-01-28
JP6114316B2 JP6114316B2 (ja) 2017-04-12

Family

ID=54261188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014558258A Active JP6114316B2 (ja) 2012-02-24 2013-02-22 カルシウム感知受容体調節剤としての置換クロマン化合物

Country Status (44)

Country Link
US (3) US9163001B2 (enExample)
EP (1) EP2817299B1 (enExample)
JP (1) JP6114316B2 (enExample)
KR (1) KR102041154B1 (enExample)
CN (1) CN104350047B (enExample)
AP (1) AP2014007919A0 (enExample)
AR (1) AR090135A1 (enExample)
AU (1) AU2013223715B2 (enExample)
BR (1) BR112014021133B1 (enExample)
CA (1) CA2864332C (enExample)
CL (1) CL2014002218A1 (enExample)
CO (1) CO7160018A2 (enExample)
CR (1) CR20140424A (enExample)
CU (1) CU24325B1 (enExample)
CY (1) CY1122017T1 (enExample)
DK (1) DK2817299T3 (enExample)
DO (1) DOP2014000193A (enExample)
EA (1) EA026940B9 (enExample)
ES (1) ES2743492T3 (enExample)
GE (2) GEAP201813579A (enExample)
GT (1) GT201400179A (enExample)
HR (1) HRP20191606T1 (enExample)
HU (1) HUE046172T2 (enExample)
IL (1) IL234252A (enExample)
IN (1) IN2014MN01672A (enExample)
LT (1) LT2817299T (enExample)
MA (1) MA35937B1 (enExample)
MX (1) MX355670B (enExample)
MY (1) MY171374A (enExample)
NI (1) NI201400094A (enExample)
NZ (1) NZ628627A (enExample)
PE (1) PE20142281A1 (enExample)
PH (1) PH12014501891B1 (enExample)
PL (1) PL2817299T3 (enExample)
PT (1) PT2817299T (enExample)
RS (1) RS59172B1 (enExample)
SG (1) SG11201405117SA (enExample)
SI (1) SI2817299T1 (enExample)
SM (1) SMT201900506T1 (enExample)
TN (1) TN2014000352A1 (enExample)
TW (1) TWI617549B (enExample)
UA (1) UA112679C2 (enExample)
WO (1) WO2013124828A1 (enExample)
ZA (1) ZA201405990B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014021133B1 (pt) * 2012-02-24 2022-06-28 Lupin Limited Composto e composição farmacêutica
WO2014033604A1 (en) * 2012-08-27 2014-03-06 Lupin Limited Arylalkylamine compounds as calcium sensing receptor modulators
TW201602062A (zh) 2013-08-12 2016-01-16 魯賓有限公司 取代聯苯基化合物作為鈣敏感受體調節劑
AU2014313835A1 (en) 2013-08-28 2016-03-03 Lupin Atlantis Holdings Sa Substituted naphthalene compounds as calcium sensing receptor modulators
WO2015162538A1 (en) 2014-04-21 2015-10-29 Lupin Limited Heterocyclic compounds as calcium sensing receptor modulators for the treatment of hyperparathyroidism, chronic renal failure and chronic kidney disease
WO2017037616A1 (en) 2015-08-31 2017-03-09 Lupin Limited Arylalkylamine compounds as calcium sensing receptor modulators
US12421204B2 (en) 2019-11-19 2025-09-23 Lupin Limited Process for preparing chroman compounds
JP7720306B2 (ja) * 2019-12-27 2025-08-07 ルピン・リミテッド CaSRモジュレーターの医薬組成物ならびにその方法および使用
BR112022013865A2 (pt) * 2020-01-17 2022-09-13 Lupin Ltd Métodos e composto
WO2025255092A1 (en) * 2024-06-03 2025-12-11 Artax Biopharma Inc. Combination of a chromene derivative tcr inhibitor and a tyk2 inhibitor

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0020018B1 (en) * 1979-05-19 1983-06-01 Beecham Group Plc Chroman derivatives, processes for their preparation and pharmaceutical compositions containing them
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
FR2809396B1 (fr) 2000-05-24 2005-10-14 Centre Nat Rech Scient Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
FR2812875B1 (fr) 2000-08-08 2003-12-12 Centre Nat Rech Scient Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation
US7105537B2 (en) 2003-01-28 2006-09-12 Bristol-Myers Squibb Company 2-substituted cyclic amines as calcium sensing receptor modulators
WO2004106280A1 (ja) 2003-05-28 2004-12-09 Japan Tobacco Inc. CaSRアンタゴニスト
PT1882684E (pt) 2005-05-19 2015-02-10 Astellas Pharma Inc Derivado de pirrolidina ou um seu sal
TW200815388A (en) 2006-04-18 2008-04-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
MX2009003673A (es) 2006-10-04 2009-04-22 Pfizer Prod Inc Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio.
EP2079525A1 (en) * 2006-10-26 2009-07-22 Amgen Inc. Calcium receptor modulating agents
WO2008059854A1 (en) 2006-11-16 2008-05-22 Astellas Pharma Inc. Piperidine derivatives or salts thereof
JP5478496B2 (ja) * 2007-10-15 2014-04-23 アムジエン・インコーポレーテツド カルシウム受容体調節剤
AU2008328362A1 (en) 2007-11-23 2009-05-28 Leo Pharma A/S Novel cyclic hydrocarbon compounds for the treatment of diseases
KR101700152B1 (ko) 2008-10-03 2017-01-26 이에이 파마 가부시키가이샤 CaSR 효능제
WO2010042642A1 (en) 2008-10-08 2010-04-15 Amgen Inc. Calcium receptor modulating agents
WO2010136037A1 (en) 2009-05-27 2010-12-02 Leo Pharma A/S Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
WO2010150837A1 (ja) 2009-06-25 2010-12-29 第一三共株式会社 インドリン誘導体
JP2014508103A (ja) 2010-11-26 2014-04-03 レオ ファーマ アクティーゼルスカブ カルシウム感知受容体活性化合物
JP2014507375A (ja) 2010-11-26 2014-03-27 レオ ファーマ アクティーゼルスカブ カルシウム感知受容体活性化合物
WO2012069402A1 (en) 2010-11-26 2012-05-31 Leo Pharma A/S Substituted cyclopentyl - azines as casr- active compounds
AU2012226375B2 (en) 2011-03-10 2017-04-13 Lupin Atlantis Holdings Sa Substituted morpholines as modulators for the calcium sensing receptor
CN103459377B (zh) 2011-03-18 2016-09-07 鲁平有限公司 作为钙敏感受体调变剂的苯并[b][1,4]噁嗪衍生物
BR112014021133B1 (pt) * 2012-02-24 2022-06-28 Lupin Limited Composto e composição farmacêutica

Similar Documents

Publication Publication Date Title
JP2015508097A5 (enExample)
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
RU2383524C2 (ru) Гексафторизопропанол-замещенные производные простых эфиров
JP2012506896A5 (enExample)
RU2481330C2 (ru) Азотсодержащее ароматическое гетероциклическое соединение
CA2407149A1 (en) Melanin-concentrating hormone antagonist
JP2004508357A5 (enExample)
JP2010529147A5 (enExample)
JP2017526727A5 (enExample)
CH620415A5 (enExample)
RU2012132692A (ru) Новые ингибиторы s-нитрозоглутатионредуктазы
JP2004529145A5 (enExample)
JP2010522710A5 (enExample)
JP2006520755A5 (enExample)
JP2020527175A5 (enExample)
JP2012507535A5 (enExample)
RU2481345C2 (ru) Замещенные (оксазолидинон-5-ил-метил)-2-тиофен-карбоксамиды и их применение в области свертывания крови
JP2017505293A5 (enExample)
JP2010516701A5 (enExample)
JP6227635B2 (ja) 重水素化ベンゾピラン類化合物及びその応用
JP2016504992A5 (enExample)
JP2004525184A5 (enExample)
CN1202104C (zh) 2-苯基吡喃-4-酮衍生物
RU2466127C2 (ru) Бензилпиперидиновое производное
JP2010504321A5 (enExample)